Trial Condition(s):
A retrospective cohort study on treatment patterns and burden of disease using Japanese claims database in patient with Diabetic Kidney Disease
20011
Not Available
Not Available
Not Available
The primary objective is to describe patient profile and health outcomes in DKD cohort and describe MRA treatment characteristics in a MRA sub-cohort. The secondary objective is to evaluate health care resource utilizations and costs in DKD cohort.
For DKD cohort: - Patients who have a claim with a diagnosis of DM (ICD-10: E10-E14) - Patients with the evidence of CKD (eGFR less than 60 ml/min/1.73m2) during the study period - Patients must have DM drugs during pre-index period or index month For MRA cohort: - Patients with a claim for a MRA drug during the study period any time after their DKD index date. Index date was defined as the first MRA prescription after their DKD index date
For DKD cohort: - Patients who do not have at least 2 claims within the 1 year follow up period - Patients who do not have at least 1 claim within the 6 months pre-index period - Patients with a diagnosis of ESRD, PKD, or IGA within the pre-index period For MRA cohort: - Patients who do not have at least 2 claims within the 1 year follow up period - Patients who do not have at least 1 claim within the pre-index period - Patients with a diagnosis of ESRD, PKD, or IGA within the pre-index period
Locations | |
---|---|
Locations Investigative Site Many locations, Japan | Contact Us: E-mail: [email protected] Phone: (+)1-888-84 22937 |
A retrospective cohort study on treatment patterns and burden of disease using Japanese claims database in patient with Diabetic Kidney Disease
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
2